Bridgewater Associates’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,292
| Closed | -$511K | – | 945 |
|
|
2024
Q1 | $511K | Sell |
1,292
-3,101
| -71% | -$1.23M | ﹤0.01% | 621 |
|
|
2023
Q4 | $1.55M | Sell |
4,393
-262
| -6% | -$92.3K | 0.01% | 568 |
|
|
2023
Q3 | $1.75M | Sell |
4,655
-280
| -6% | -$105K | 0.01% | 517 |
|
|
2023
Q2 | $1.89M | Sell |
4,935
-30
| -0.6% | -$11.5K | 0.01% | 469 |
|
|
2023
Q1 | $1.72M | Sell |
4,965
-7,254
| -59% | -$2.51M | 0.01% | 485 |
|
|
2022
Q4 | $2.88M | Sell |
12,219
-29,858
| -71% | -$7.03M | 0.02% | 466 |
|
|
2022
Q3 | $10.4M | Buy |
42,077
+18,921
| +82% | +$4.66M | 0.05% | 248 |
|
|
2022
Q2 | $7M | Buy |
23,156
+12,266
| +113% | +$3.71M | 0.03% | 411 |
|
|
2022
Q1 | $4.47M | Buy |
10,890
+2,525
| +30% | +$1.04M | 0.02% | 496 |
|
|
2021
Q4 | $3.92M | Sell |
8,365
-75,708
| -90% | -$35.5M | 0.02% | 349 |
|
|
2021
Q3 | $35.7M | Sell |
84,073
-3,495
| -4% | -$1.48M | 0.2% | 96 |
|
|
2021
Q2 | $31.4M | Buy |
87,568
+39,073
| +81% | +$14M | 0.2% | 90 |
|
|
2021
Q1 | $13.7M | Buy |
48,495
+6,132
| +14% | +$1.73M | 0.12% | 132 |
|
|
2020
Q4 | $12M | Buy |
42,363
+24,718
| +140% | +$7M | 0.1% | 108 |
|
|
2020
Q3 | $4.85M | Buy |
+17,645
| New | +$4.85M | 0.06% | 142 |
|